Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Adenocarcinoma, Scirrhous

ClinicalTrials.gov lists 1 trial for Adenocarcinoma, Scirrhous or a narrower condition beneath it. Novartis Pharmaceuticals has the most among industry and government lead sponsors, with 1.

MeSH D002293 Neoplasms Neoplasm C04
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Lead sponsors Lead sponsors 1 Publications Publications 3 Sub-conditions in MeSH Sub-conditions in MeSH 1 Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Lead sponsors Lead sponsors 1 Publications Publications 3 Sub-conditions in MeSH Sub-conditions in MeSH 1

Rows recorded per section

3 sections measured, none recorded · 1 not measured yet · 1 not computed

1 of the 1 trial is tagged with Adenocarcinoma, Scirrhous itself; the rest are tagged with a narrower condition beneath it.

Get the Adenocarcinoma, Scirrhous report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Adenocarcinoma, Scirrhous trials start? (1)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2012 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Adenocarcinoma, Scirrhous trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 2 1

How many Adenocarcinoma, Scirrhous trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Completed 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Adenocarcinoma, Scirrhous trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Novartis Pharmaceuticals 1

Which publications cover Adenocarcinoma, Scirrhous? (3)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. International journal of cancer 2014 Yes
[Autoradiographic study of the gastric mucosa in cancer]. Voprosy onkologii 1976 Yes
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta pathologica et microbiologica Scandinavica 1965 Yes

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages